89 related articles for article (PubMed ID: 8344641)
1. Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice.
Tokuyama Y; Kanatsuka A; Yamaguchi T; Ohsawa H; Makino H; Nishimura M; Yoshida S
Horm Metab Res; 1993 Jun; 25(6):289-91. PubMed ID: 8344641
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide/amylin contents in pancreas change with increasing age in genetically obese and diabetic mice.
Takada K; Kanatsuka A; Tokuyama Y; Yagui K; Nishimura M; Saito Y; Makino H
Diabetes Res Clin Pract; 1996 Aug; 33(3):153-8. PubMed ID: 8922536
[TBL] [Abstract][Full Text] [Related]
3. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
4. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
[TBL] [Abstract][Full Text] [Related]
5. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
Leckström A; Ziv E; Shafrir E; Westermark P
Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089
[TBL] [Abstract][Full Text] [Related]
6. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
7. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
Westermark P
Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic somatostatin contents in spontaneously diabetic KK and non-obese diabetic (NOD) mice.
Matsushima Y; Makino H; Kanatsuka A; Osegawa M; Kumagai A; Nishimura M; Tochino Y; Makino S
Horm Metab Res; 1982 Jun; 14(6):292-8. PubMed ID: 6126426
[TBL] [Abstract][Full Text] [Related]
10. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
Koopmans SJ; Radder JK; Krans HM; Barge RM
Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
[TBL] [Abstract][Full Text] [Related]
11. Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice.
Mulder H; Mårtensson H; Sundler F; Ahrén B
Metabolism; 2000 Dec; 49(12):1518-22. PubMed ID: 11145110
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
13. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice.
Vicario PP; Slater EE; Saperstein R
Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726
[TBL] [Abstract][Full Text] [Related]
14. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse.
Leckström A; Lundquist I; Ma Z; Westermark P
Pancreas; 1999 Apr; 18(3):266-73. PubMed ID: 10206485
[TBL] [Abstract][Full Text] [Related]
15. Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging.
Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
Metabolism; 1993 May; 42(5):654-8. PubMed ID: 8492723
[TBL] [Abstract][Full Text] [Related]
16. Depletion of islet amyloid polypeptide in the spontaneously diabetic (BB) Wistar rat.
Bretherton-Watt D; Ghatei MA; Legon S; Jamal H; Suda K; Bloom SR
J Mol Endocrinol; 1991 Feb; 6(1):3-7. PubMed ID: 2015054
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor number in ob/ob mice and streptozotocin-treated rats.
Svec F
Horm Metab Res; 1985 Aug; 17(8):396-8. PubMed ID: 4054827
[TBL] [Abstract][Full Text] [Related]
18. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia.
Pieber TR; Stein DT; Ogawa A; Alam T; Ohneda M; McCorkle K; Chen L; McGarry JD; Unger RH
Am J Physiol; 1993 Sep; 265(3 Pt 1):E446-53. PubMed ID: 8105694
[TBL] [Abstract][Full Text] [Related]
19. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin.
Jamal H; Bretherton-Watt D; Suda K; Ghatei MA; Bloom SR
J Endocrinol; 1990 Sep; 126(3):425-9. PubMed ID: 2212934
[TBL] [Abstract][Full Text] [Related]
20. Beta-cell tropin- and glucose-induced hypersecretion of insulin and amylin from perfused fatty rat pancreas.
Dunmore SJ; Cawthorne MA; Hislop DC; Morton JL; Beloff-Chain A
J Endocrinol; 1993 Jun; 137(3):375-81. PubMed ID: 8396617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
